ClickStream Corp

2022 Q3 Form 10-Q Financial Statement

#000157570522000610 Filed on August 22, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.000K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $880.0K
Receivables
Other Receivables
Total Short-Term Assets $881.0K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $881.0K
Total Long-Term Assets $0.00
Total Assets $881.0K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.958M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.958M
Total Long-Term Liabilities
Total Liabilities $1.958M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$18.16M
YoY Change
Common Stock $34.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.123M -$278.0K
YoY Change
Total Liabilities & Shareholders Equity $881.0K
YoY Change

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001393548
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q2 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
usd
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
usd
CY2021Q3 clis Common Stock Issuable
CommonStockIssuable
shares
CY2022Q2 us-gaap Revenues
Revenues
usd
CY2021Q2 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2022Q2 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
usd
CY2021Q2 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
CY2022Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
usd
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
usd
CY2021Q2 clis Deemed Dividend Resulting From Redemption Of Series Shares
DeemedDividendResultingFromRedemptionOfSeriesShares
usd
clis Deemed Dividend Resulting From Redemption Of Series Shares
DeemedDividendResultingFromRedemptionOfSeriesShares
usd
CY2022Q2 clis Physical Issuance Of Common Shares Previously To Be Issued
PhysicalIssuanceOfCommonSharesPreviouslyToBeIssued
usd
clis Physical Issuance Of Common Shares Previously To Be Issued
PhysicalIssuanceOfCommonSharesPreviouslyToBeIssued
usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
usd
clis Change In Fair Value Investments Related Party
ChangeInFairValueInvestmentsRelatedParty
usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
usd
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
usd
us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
usd
clis Interest Receivable Related Party
InterestReceivableRelatedParty
usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
usd
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
clis Proceeds From Note Payable To Winners Inc.Related Party
ProceedsFromNotePayableToWinnersInc.RelatedParty
usd
clis Redemption Of Series Preferred Shares
RedemptionOfSeriesPreferredShares
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
clis Common Shares Issued To Settle Accrued Expenses
CommonSharesIssuedToSettleAccruedExpenses
usd
clis Deemed Dividend Resulting From Redemption Of Series Shares
DeemedDividendResultingFromRedemptionOfSeriesShares
usd
clis Common Shares Issued For Prepaid Expenses
CommonSharesIssuedForPrepaidExpenses
usd
clis Common Shares Issued Upon Conversions Of Convertible Notes Payable
CommonSharesIssuedUponConversionsOfConvertibleNotesPayable
usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
usd
CY2022Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
usd
CY2022Q2 clis Accrued Interest Receivable
AccruedInterestReceivable
usd
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
usd
CY2022Q2 us-gaap Other Assets
OtherAssets
usd
CY2021Q3 us-gaap Notes Payable
NotesPayable
usd
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
usd
CY2021Q3 us-gaap Other Liabilities
OtherLiabilities
usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
usd
CY2021Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
usd
CY2021Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
usd
CY2021Q3 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
usd
CY2021Q3 clis Convertible Notes Payable Net Of Unamortized Debt Discount Plus Debt Premium
ConvertibleNotesPayableNetOfUnamortizedDebtDiscountPlusDebtPremium
usd
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
CY2022Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
usd
CY2021Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-52944
dei Entity Registrant Name
EntityRegistrantName
Clickstream Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5582243
dei Entity Address Address Line1
EntityAddressAddressLine1
8549 Wilshire Blvd
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2181
dei Entity Address City Or Town
EntityAddressCityOrTown
Beverly Hills
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90211
dei City Area Code
CityAreaCode
(213)
dei Local Phone Number
LocalPhoneNumber
205-0684
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
CLIS
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
343285671 shares
CY2022Q2 us-gaap Cash
Cash
1000 usd
CY2021Q3 us-gaap Cash
Cash
422000 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
880000 usd
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
102000 usd
CY2021Q3 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
556000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
881000 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
1080000 usd
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
105000 usd
CY2022Q2 us-gaap Assets
Assets
881000 usd
CY2021Q3 us-gaap Assets
Assets
1185000 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1070000 usd
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
207000 usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
775000 usd
CY2022Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
113000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1958000 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
207000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
1958000 usd
CY2021Q3 us-gaap Liabilities
Liabilities
207000 usd
CY2022Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
46000 usd
CY2021Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
50000 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
338183630 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
338183630 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
279437804 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
279437804 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
34000 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
28000 usd
CY2022Q2 clis Common Stock Shares Issuable
CommonStockSharesIssuable
18087827 usd
CY2021Q3 clis Common Stock Shares Issuable
CommonStockSharesIssuable
140000 usd
CY2022Q2 clis Common Stock Issuable
CommonStockIssuable
2000 shares
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16996000 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14464000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18155000 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13564000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1123000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
928000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
881000 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1185000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
189000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
230000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
484000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
521000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
741000 usd
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1027000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3582000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5389000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
930000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
1257000 usd
us-gaap Operating Expenses
OperatingExpenses
4066000 usd
us-gaap Operating Expenses
OperatingExpenses
5910000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-930000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1257000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4066000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5910000 usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
-146000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
60000 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
74000 usd
us-gaap Interest Expense
InterestExpense
267000 usd
us-gaap Interest Expense
InterestExpense
90000 usd
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
13000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
21000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
41000 usd
CY2021Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
377000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
639000 usd
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
35000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
35000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-25000 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
316000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-357000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
590000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-955000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-941000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4423000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5320000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-105000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-955000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-941000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4528000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5320000 usd
CY2022Q2 clis Deemed Dividend Resulting From Redemption Of Series Shares
DeemedDividendResultingFromRedemptionOfSeriesShares
12000 usd
clis Deemed Dividend Resulting From Redemption Of Series Shares
DeemedDividendResultingFromRedemptionOfSeriesShares
63000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-967000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-941000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4591000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5320000 usd
CY2022Q2 clis Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.00
CY2021Q2 clis Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.00
clis Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.01
clis Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.02
CY2022Q2 clis Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
349072877 shares
CY2021Q2 clis Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
244277687 shares
clis Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
316264509 shares
clis Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
234539844 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-278000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
62000 usd
CY2022Q2 clis Redemptiono Of Series A Preferred Shares
RedemptionoOfSeriesAPreferredShares
-12000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
60000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-955000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1123000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
928000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
795000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
750000 usd
clis Issuance Of Shares For Settlement Of Employment Agreement
IssuanceOfSharesForSettlementOfEmploymentAgreement
155000 usd
clis Issuance Of Common Shares For Marketing Fees
IssuanceOfCommonSharesForMarketingFees
390000 usd
clis Issuance Of Common Shares For Licensing Fees
IssuanceOfCommonSharesForLicensingFees
390000 usd
clis Deemed Dividend Related To Redemption Of Series Preferred Shares
DeemedDividendRelatedToRedemptionOfSeriesPreferredShares
-63000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
60000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4528000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1123000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
2496000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
89000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-941000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1644000 usd
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
4245000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2591000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
128000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5320000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1644000 usd
us-gaap Profit Loss
ProfitLoss
-4528000 usd
us-gaap Profit Loss
ProfitLoss
-5320000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
130000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
90000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
105000 usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
-146000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
35000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
698000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2591000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-105000 usd
clis Change In Fair Value Investments Related Party
ChangeInFairValueInvestmentsRelatedParty
639000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-98000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-982000 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
21000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
873000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-75000 usd
clis Accrued Interest Payable Related Party
AccruedInterestPayableRelatedParty
2000 usd
clis Accrued Interest Payable Related Party
AccruedInterestPayableRelatedParty
-4000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2427000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2375000 usd
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
315000 usd
us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
577000 usd
clis Interest Receivable Related Party
InterestReceivableRelatedParty
-41000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
577000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-356000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
754000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1300000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
119000 usd
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
7000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
750000 usd
clis Proceeds From Note Payable To Winners Inc.Related Party
ProceedsFromNotePayableToWinnersInc.RelatedParty
111000 usd
clis Redemption Of Series Preferred Shares
RedemptionOfSeriesPreferredShares
67000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1429000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1293000 usd
CY2021Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0 usd
CY2021Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
172000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-421000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1438000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
422000 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3015000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1577000 usd
clis Common Shares Issued To Settle Accrued Expenses
CommonSharesIssuedToSettleAccruedExpenses
9000 usd
clis Deemed Dividend Resulting From Redemption Of Series Shares
DeemedDividendResultingFromRedemptionOfSeriesShares
63000 usd
clis Common Shares Issued For Prepaid Expenses
CommonSharesIssuedForPrepaidExpenses
877000 usd
clis Common Shares Issued Upon Conversions Of Convertible Notes Payable
CommonSharesIssuedUponConversionsOfConvertibleNotesPayable
60000 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
128000 usd
CY2022Q2 us-gaap Cash
Cash
1000 usd
CY2022Q2 clis Working Capital Deficit
WorkingCapitalDeficit
1077000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4591000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2427000 usd
CY2022Q2 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
600000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zYQBAC13Ypq4" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline"><span id="xdx_86E_zwq6RMdprPRd">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the relative fair value of assets acquired, valuation of intangible assets for impairment testing, valuation of share-based compensation, and the valuation allowance on deferred tax assets. Actual results could differ from those estimates, and those estimates may be material.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
199000 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
515000 usd
CY2022Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
209000 usd
CY2022Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
408000 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
25000 usd
CY2021 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
128000 usd
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
413874814 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000000 shares
CY2021Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
515000 usd
CY2021Q3 clis Accrued Interest Receivable
AccruedInterestReceivable
41000 usd
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
105000 usd
CY2021Q3 us-gaap Other Assets
OtherAssets
661000 usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
111000 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
2000 usd
CY2022Q2 us-gaap Other Liabilities
OtherLiabilities
113000 usd
CY2020Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
350000 usd
CY2020 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
150000 usd
CY2021Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
315000 usd
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
515000 usd
clis Repayment Of Interest
RepaymentOfInterest
62000 usd
CY2022Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
0 usd
us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
21000 usd
CY2022Q2 us-gaap Accrued Fees And Other Revenue Receivable
AccruedFeesAndOtherRevenueReceivable
62000 usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
111000 usd
CY2022Q2 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
2000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2370000 usd
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
128000 usd
CY2021Q3 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
1456000 usd
CY2021Q3 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.5499 pure
CY2021Q3 us-gaap Equity Method Investment Quoted Market Value
EquityMethodInvestmentQuotedMarketValue
800000 usd
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
175000 usd
CY2022Q2 us-gaap Business Combination Acquired Receivables Fair Value
BusinessCombinationAcquiredReceivablesFairValue
17000 usd
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
192000 usd
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
192000 usd
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-87000 usd
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
105000 usd
CY2021Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-105000 usd
CY2022Q2 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
154012000 shares
CY2022Q2 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1524719 usd
CY2022Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
752000 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
32000 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
55000 usd
CY2022Q2 clis Convertible Notes Payable Net Of Unamortized Debt Discount Plus Debt Premium
ConvertibleNotesPayableNetOfUnamortizedDebtDiscountPlusDebtPremium
775000 usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
775000 usd
us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
809000 usd
us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
650000 usd
us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
515000 usd
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
62000 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
63000 usd
CY2022Q2 us-gaap Due To Affiliate Noncurrent
DueToAffiliateNoncurrent
33000 usd
clis Stockholders Equity Note Disclosure Text Bloc
StockholdersEquityNoteDisclosureTextBloc
<p id="xdx_807_ecustom--StockholdersEquityNoteDisclosureTextBloc_zsERJC0bP3fh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 11 - <span id="xdx_826_z01RLhQ6ZFR4">STOCKHOLDERS’ EQUITY (DEFICIT)</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Issuance of Common Shares for Services</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended June 30, 2022, the Company agreed to issue a total of 24,387,257 shares of common stock, of which 21,299,430 shares were issued and 3,087,827 are to be issued, to consultants with a fair value of $795,000 for services rendered, of which $311,000 is included in prepaid expenses as of June 30, 2022 and is being amortized over the respective service period or agreement term. The common shares issued were valued at the trading price at the respective date of issuances.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended June 30, 2021, the Company issued a total of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesOther_c20201001__20210630__srt--TitleOfIndividualAxis__custom--ConsultantsMember_zmmH0AGdx1Ml">13,877,179</span> shares of common stock to consultants with a fair value of $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueOther_c20201001__20210630__srt--TitleOfIndividualAxis__custom--ConsultantsMember_zxYvZVel5CGc">2,591,000</span> for services rendered.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Issuance of Common Shares for Licensing and Marketing Fees</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Effective March 29, 2022, the Company entered into a Collaboration Agreement (the “Agreement”) with The Stan Lee Estate (“SLE”) and Roc Nation LLC (“Roc Nation”) pursuant to which the parties will collaborate in the mining, marketing and distributing of non-fungible tokens (“NFTs) of among other things data, art, assets, expressions and any other information, expressions and renderings of or related to SLE that SLE owns, controls or otherwise has the right to use and distribute on a non-exclusive and exclusive basis including 147 original art drawings by Stan Lee and autographed by Stan Lee as one NFT, Stan Lee original drawings of Spiderman Circa 1940’s, Stan Lee/Charles Schultz collaboration painting of Snoopy and Spiderman, Silver Surfer artwork original and Spiderman woven tapestry original.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">For its compensation under the Agreement, the Company will receive 10% of net revenues from original issue NFT’s and 20% of all resale net revenues. In turn, the Company will issue to SLE: (a) 15,000,000 restricted shares of the Company’s common stock upon execution of the Agreement; and (b) 10,000,000 restricted shares of the Company’s Common Stock after in each case NFT gross sales reach $1,000,000, $10,000,000 and $20,000,000. Additionally, SLE is to receive a series of 5% equity interests in Rebel after in each case NFT gross sales reach $1,000,000, $5,000,000, $75,000,000 and $100,000,000. Also, Roc Nation is to receive 15,000,000 restricted shares of the Company’s Common Stock upon execution of this Agreement and 5,000,000 restricted shares when NFT gross sales reach $10,000,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">During the nine months ended June 30, 2022, the 15,000,000 common shares required to be issued to SLE upon execution of the Agreement resulted in prepaid licensing fees of $390,000, which is being amortized to expense over the one-year term of the Agreement. As of June 30, 2022, the amount remaining in prepaid expense was $283,000. As of June 30, 2022, the 15,000,000 common shares to SLE are shown as common stock to be issued on the accompanying consolidated balance sheet. The 15,000,000 common shares required to be issued to Roc Nation upon execution of the Agreement resulted in prepaid marketing fees of $390,000, which is being amortized to advertising expense over the one-year term of the Agreement. As of June 30, 2022, the amount remaining in prepaid expense was $283,000. Effective March 29, 2022, the 15,000,000 common shares to Roc Nation were issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Issuance of Common Shares for Settlement of Employment Agreement</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 14, 2021, the Company issued a total of 1,550,000 shares of common stock as settlement of an employment agreement with a former employee. The common shares were valued at the trading price of $0.10 on the settlement date or $155,000. As there was $9,000 accrued to the employee, the Company recognized a loss on the settlement of $146,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Issuance of Common Shares for Cash</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended June 30, 2022, the Company issued a total of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211001__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zL7VtDCBIYSk">15,000,000 </span>shares of common stock in a private placement offering for cash proceeds of $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20211001__20220630_zmm44F5hcQ1c">750,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Issuance of Common Shares Upon Conversions of Convertible Notes Payable </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended June 30, 2022, a noteholder converted an aggregate of $45,000 of principal into 5,756,396 shares of common stock, resulting in a reduction in convertible notes payable by $45,000 and debt premium by $15,000, with a corresponding increase in common stock of $1,000 and additional paid-in capital of $59,000 (See Note 8).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Issuance of Common Shares to be Issued</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 13, 2022, the Company issued 140,000 common shares that were previously to be issued as of September 30, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Issuance of Common Shares for Acquisition</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended June 30, 2021, the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20201001__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zrtQUc1DcZDg">10,000,000</span> shares of common stock to acquire 100% of Nebula Software Corp. with a fair value of $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pp0p0_c20201001__20210630_z3FwTI3gdew1">128,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
750000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
128000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
189000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
484000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
230000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
521000 usd
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
CY2021Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd

Files In Submission

Name View Source Status
0001575705-22-000610-index-headers.html Edgar Link pending
0001575705-22-000610-index.html Edgar Link pending
0001575705-22-000610.txt Edgar Link pending
0001575705-22-000610-xbrl.zip Edgar Link pending
clis-20220630.xsd Edgar Link pending
clis_10q.htm Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
clis-20220630_lab.xml Edgar Link unprocessable
clis-20220630_pre.xml Edgar Link unprocessable
clis-20220630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
clis_10q_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
clis-20220630_cal.xml Edgar Link unprocessable